Federated Hermes
BEAM icon

Federated Hermes’s Beam Therapeutics BEAM Stock Holding History

Federated Hermes’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$572 Sell
24
-71
-75% -$1.97K ﹤0.01% 2027
2025
Q4 		$2.63K Sell
95
-29,155
-100% -$744K ﹤0.01% 1952
2025
Q3 		$710K Buy
29,250
+85
+0.3% +$1.69K ﹤0.01% 1250
2025
Q2 		$496K Sell
29,165
-964
-3% -$16.8K ﹤0.01% 1334
2025
Q1 		$588K Buy
30,129
+420
+1% +$11K ﹤0.01% 1258
2024
Q4 		$737K Sell
29,709
-7,792
-21% -$199K ﹤0.01% 1211
2024
Q3 		$919K Buy
37,501
+16,662
+80% +$430K ﹤0.01% 1146
2024
Q2 		$488K Buy
+20,839
New +$512K ﹤0.01% 1320
2023
Q4 		– Sell
-10,000
Closed -$241K – 2053
2023
Q3 		$241K Hold
10,000
– – ﹤0.01% 1501
2023
Q2 		$319K Hold
10,000
– – ﹤0.01% 1484
2023
Q1 		$306K Buy
+10,000
New +$395K ﹤0.01% 1520
2021
Q3 		– Sell
-7,692
Closed -$990K – 2215
2021
Q2 		$990K Sell
7,692
-45,696
-86% -$3.64M ﹤0.01% 1323
2021
Q1 		$4.27M Sell
53,388
-49,218
-48% -$4.68M 0.01% 894
2020
Q4 		$8.38M Buy
+102,606
New +$5.05M 0.02% 688
2020
Q3 		– Sell
-17,554
Closed -$492K – 2251
2020
Q2 		$492K Buy
+17,554
New +$378K ﹤0.01% 1481

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Federated Hermes's BEAM Position: Q1 2026 in Review

Federated Hermes reduced its Beam Therapeutics (BEAM) stake by 75% in Q1 2026, selling an estimated $1.97K and leaving 24 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Federated Hermes first reported a position in BEAM in Q2 2020 and has held it in 15 quarters since. The position peaked at $8.38M in Q4 2020. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Federated Hermes held 24 shares of Beam Therapeutics worth $572 as of Q1 2026.
  • Federated Hermes sold 71 Beam Therapeutics shares in Q1 2026, an estimated $1.97K.
  • Beam Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #2027 holding.
  • Federated Hermes first reported a position in Beam Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • Federated Hermes's Beam Therapeutics position peaked at $8.38M in Q4 2020.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.